- Home
- IMMP vs VUZI Comparison
IMMP vs VUZI Comparison
Compare IMMP & VUZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- VUZI
- Stock Information
- Founded
- IMMP 1987
- VUZI 1997
- Country
- IMMP Australia
- VUZI United States
- Employees
- IMMP N/A
- VUZI N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- VUZI Industrial Machinery/Components
- Sector
- IMMP Health Care
- VUZI Technology
- Exchange
- IMMP Nasdaq
- VUZI Nasdaq
- Market Cap
- IMMP 251.8M
- VUZI 236.4M
- IPO Year
- IMMP N/A
- VUZI N/A
- Fundamental
- Price
- IMMP $1.57
- VUZI $2.82
- Analyst Decision
- IMMP Buy
- VUZI Strong Buy
- Analyst Count
- IMMP 1
- VUZI 1
- Target Price
- IMMP $7.00
- VUZI $2.00
- AVG Volume (30 Days)
- IMMP 111.5K
- VUZI 2.0M
- Earning Date
- IMMP 02-27-2025
- VUZI 08-13-2025
- Dividend Yield
- IMMP N/A
- VUZI N/A
- EPS Growth
- IMMP N/A
- VUZI N/A
- EPS
- IMMP N/A
- VUZI N/A
- Revenue
- IMMP $3,019,249.00
- VUZI $5,331,630.00
- Revenue This Year
- IMMP $50.37
- VUZI $45.35
- Revenue Next Year
- IMMP N/A
- VUZI $54.01
- P/E Ratio
- IMMP N/A
- VUZI N/A
- Revenue Growth
- IMMP 24.11
- VUZI N/A
- 52 Week Low
- IMMP $1.32
- VUZI $0.83
- 52 Week High
- IMMP $2.80
- VUZI $5.79
- Technical
- Relative Strength Index (RSI)
- IMMP 36.75
- VUZI 50.52
- Support Level
- IMMP $1.51
- VUZI $2.67
- Resistance Level
- IMMP $1.63
- VUZI $3.29
- Average True Range (ATR)
- IMMP 0.07
- VUZI 0.21
- MACD
- IMMP -0.03
- VUZI -0.06
- Stochastic Oscillator
- IMMP 14.34
- VUZI 21.05
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About VUZI Vuzix Corporation
Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.